BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6509027)

  • 1. Hydroperoxides as inactivators of aromatase: 10 beta-hydroperoxy-4-estrene-3,17-dione, crystal structure and inactivation characteristics.
    Covey DF; Hood WF; Beusen DD; Carrell HL
    Biochemistry; 1984 Nov; 23(23):5398-406. PubMed ID: 6509027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of human placental aromatase by 6 alpha- and 6 beta-hydroperoxyandrostenedione.
    Tan L; Petit A
    Biochem Biophys Res Commun; 1985 Apr; 128(2):613-20. PubMed ID: 3994715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
    Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
    Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivatives.
    Bellino FL; Gilani SS; Eng SS; Osawa Y; Duax WL
    Biochemistry; 1976 Oct; 15(21):4730-6. PubMed ID: 974087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors.
    Lovett JA; Darby MV; Counsell RE
    J Med Chem; 1984 Jun; 27(6):734-40. PubMed ID: 6547488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and properties of the epimeric 6-hydroperoxyandrostenediones, new substrates/inhibitors of human placental aromatase.
    Tan L; Hrycay EG; Matsumoto K
    J Steroid Biochem; 1983 Sep; 19(3):1329-38. PubMed ID: 6621039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiol-containing androgens as suicide substrates of aromatase.
    Bednarski PJ; Porubek DJ; Nelson SD
    J Med Chem; 1985 Jun; 28(6):775-9. PubMed ID: 4009599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
    Numazawa M; Tachibana M
    Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
    Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
    J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity of the placental microsomal aromatase.
    Gibb W; Lavoie JC
    Steroids; 1980 Nov; 36(5):507-19. PubMed ID: 7456098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of action of the aromatase inhibitor, 4-hydroxyandrostenedione.
    Abul-Hajj YJ
    Steroids; 1983 Jun; 41(6):783-90. PubMed ID: 6665821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive product inhibition of aromatase by natural estrogens.
    Shimizu Y; Yarborough C; Osawa Y
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):651-6. PubMed ID: 8476777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10 beta-propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis.
    Covey DF; Hood WF; Parikh VD
    J Biol Chem; 1981 Feb; 256(3):1076-9. PubMed ID: 7451489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of mechanism-based inactivators of human placental aromatase.
    Marcotte PA; Robinson CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3322s-3326s. PubMed ID: 7083194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 10 beta-substituted 4-estrene-3, 17-diones as inhibitors of human placental microsomal aromatase.
    Marcotte PA; Robinson CH
    Steroids; 1982 Mar; 39(3):325-44. PubMed ID: 7090028
    [No Abstract]   [Full Text] [Related]  

  • 16. Stereochemistry of the functional group determines the mechanism of aromatase inhibition by 6-bromoandrostenedione.
    Osawa Y; Osawa Y; Coon MJ
    Endocrinology; 1987 Sep; 121(3):1010-6. PubMed ID: 3622372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative requirements for NADPH in the support of aromatization by human placental microsomes.
    Sheean LA; Meigs RA
    Steroids; 1981 Aug; 38(2):211-20. PubMed ID: 7303032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of reversible inhibition of 16alpha-hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization.
    Numazawa M; Mutsumi A; Tachibana M; Yoshimura A
    Biol Pharm Bull; 2003 Jun; 26(6):890-2. PubMed ID: 12808307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of 19-oxo[2 beta-2H]androgens into oestrogens by human placental aromatase. An unexpected stereochemical outcome.
    Cole PA; Robinson CH
    Biochem J; 1990 Jun; 268(3):553-61. PubMed ID: 2363692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues.
    Marcotte PA; Robinson CH
    Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.